19 Results for "

GLP-1 receptor agonist 1

" in MedChemExpress (MCE) Product Catalog:
Products (19)

19 Results for "GLP-1 receptor agonist 1" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-112185
CAS No.: 2212020-52-3
Purity:  99.80%
Synonyms: LY3502970; GLP-1 receptor agonist 1
Target:  

GCGR

Orforglipron (LY3502970) (Compound 67) is an orally active agonist for Glucagon-like peptide-1 receptor (GLP-1R), which exhibits potency in ameliorates the type 2 diabete .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-112185A
CAS No.: 3008544-96-2
Purity:  99.71%
Synonyms: LY3502970 hemicalcium hydrate; GLP-1 receptor agonist 1 hemicalcium hydrate
Target:  

GCGR

Orforglipron hemicalcium hydrate (LY3502970 hemicalcium hydrate; GLP-1 receptor agonist 1 hemicalcium hydrate) is the calcium salt hydrate form of Orforglipron (HY-112185). Orforglipron is an orally active agonist for Glucagon-like peptide-1 receptor (GLP-1R), which exhibits potency in ameliorating the type 2 diabete .
loading...
    loading...
Cat. No.: HY-153476
CAS No.: 2807481-02-1
Target:  

GCGR GLP Receptor

Research Areas:  

Inflammation/Immunology

GIP/GLP-1 dual receptor agonist-1 is a GIP/GLP-1 dual receptor agonist. GIP/GLP-1 dual receptor agonist-1 is used in the research of metabolic disorders and fatty liver diseases, including non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD) .
loading...
    loading...
Cat. No.: HY-153476A
Target:  

GLP Receptor GCGR

Research Areas:  

Inflammation/Immunology

GIP/GLP-1 dual receptor agonist-1 sodium is a GIP/GLP-1 dual receptor agonist. GIP/GLP-1 dual receptor agonist-1 sodium is used in the research of metabolic disorders and fatty liver diseases, including non-alcoholic steatohepatitis (NASH) and non-alcoholic fatty liver disease (NAFLD) .
loading...
    loading...
Cat. No.: HY-112679
CAS No.: 2230197-64-3
Purity:  98.18%
Target:  

GCGR

Research Areas:  

Inflammation/Immunology

GLP-1 receptor agonist 2 is a glucagon-like peptide-1 receptor (GLP-1R) agonist .
loading...
    loading...
Cat. No.: HY-P10302A
Target:  

GLP Receptor

GLP-1R/GIPR agonist-1 sodium is a dual GLP-1/GIP receptor agonist, with an EC50 of 0.57 nM for GLP-1R and an EC50 of 0.75 nM for GIPR. GLP-1R/GIPR agonist-1 sodium reduces food intake, inhibits weight gain, repairs islet damage, improves glucose tolerance, regulates serum lipid and liver enzyme levels, ameliorates hepatic vacuolization, reduces hepatic fat accumulation, delays the progression of hepatic fibrosis, and exhibits long-lasting hypoglycemic activity. GLP-1R/GIPR agonist-1 sodium can be used in research related to type 2 diabetes, obesity, and non-alcoholic steatohepatitis .
loading...
    loading...
Cat. No.: HY-P10929
CAS No.: 2460751-66-8
Target:  

Drug Intermediate

Research Areas:  

Others

Fmoc-Lys(tBuO-Ara-Glu(AEEA-AEEA)-OtBu)-OH is a drug intermediate in the synthesis of Tirzepatide. Tirzepatide is a dual glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 receptor (GLP-1R) agonist .
loading...
    loading...
Cat. No.: HY-P1144
CAS No.: 62340-29-8
Synonyms: Glucagon-37 (bovine, porcine)
Target:  

GCGR

Research Areas:  

Metabolic Disease

Oxyntomodulin (bovine, porcine), a 37-amino acid peptide hormone, is a glucagon-like peptide 1 (GLP-1) receptor agonist .
loading...
    loading...
Cat. No.: HY-153815
CAS No.: 2784590-83-4
Purity:  98.01%
Synonyms: GLP-1 receptor agonist 11
GLP-1 receptor agonist 11 is a GLP-1 receptor agonist .GLP-1 receptor agonist 11 activates the GLP-1 receptor [1].GLP-1 receptor agonist 11 can be used for the research of diabetes, non-alcoholic fatty liver disease, glucose intolerance, dyslipidemia, syndrome x, arteriosclerosis, hypertension, obesity, hepatic fibrosis, cirrhosis, somnolence, hyperglycemia, hyperlipidemia, atherosclerosis, hypertriglyceridemia, type 1 diabetes, type 2 diabetes, diabetic dyslipidemia .
loading...
    loading...
Cat. No.: HY-P10302
Research Areas:  

Metabolic Disease

GLP-1R/GIPR AgonIST-1 is a double-receptor agonist for GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulin releasing peptide). GLP-1R/GIPR agonist-1 lowers blood sugar by mimicking the action of endogenous hormones GLP-1 and GIP, enhancing insulin secretion while inhibiting glucagon secretion. GLP-1R/GIPR agonist-1 can be used in the study of metabolic diseases such as diabetes, obesity, and non-alcoholic steatohepatitis (NASH) .
loading...
    loading...
Cat. No.: HY-147628
CAS No.: 2763621-11-8
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

GLP-1R agonist 15 (Compound 101) is a GLP-1 receptor agonist .
loading...
    loading...
Cat. No.: HY-147626
CAS No.: 2768016-72-2
Target:  

GLP Receptor

Research Areas:  

Metabolic Disease

GLP-1R agonist 13 (Compound 24) is a GLP-1 receptor agonist .
loading...
    loading...
Cat. No.: HY-144033
CAS No.: 2711019-49-5
Research Areas:  

Metabolic Disease

GLP-1R agonist 1 is a fused imidazole GLP-1 receptor agonist with EC50 = 0.12 nM. GLP-1R agonist 1 exhibits weak inhibitory effect on hERG, with hERG potassium channel blockade IC50 = 22 μM. GLP-1R agonist 1 can be used for research on GLP-1-related diseases, such as diabetes .
loading...
    loading...
Cat. No.: HY-13443F
Synonyms: Lys27(Biotin)-Exendin 4
Target:  

GCGR

Research Areas:  

Others

Exendin 4, biotin labeled is a biotin labeled Exendin 4 (HY-13443). Exendin 4 is a long-acting GLP-1 receptor agonist .
loading...
    loading...
Cat. No.: HY-112185R
CAS No.: 2212020-52-3
Synonyms: LY3502970 (Standard); GLP-1 receptor agonist 1 (Standard)
Orforglipron (Standard) is the analytical standard of Orforglipron (HY-112185). This product is intended for research and analytical applications. Orforglipron (LY3502970) (Compound 67) is an orally active agonist for Glucagon-like peptide-1 receptor (GLP-1R), which exhibits potency in ameliorates the type 2 diabete .
loading...
    loading...
Cat. No.: HY-P1144A
Synonyms: Glucagon-37 (bovine, porcine) TFA
Target:  

GCGR

Research Areas:  

Metabolic Disease

Oxyntomodulin (bovine, porcine) TFA, a 37-amino acid peptide hormone, is a glucagon-like peptide 1 (GLP-1) receptor agonist .
loading...
    loading...
Cat. No.: HY-172673
CAS No.: 2922542-61-6
Target:  

GCGR

Research Areas:  

Metabolic Disease

GLP-1R agonist 31 (Compound 1) is an amorphous glucagon-like peptide-1 receptor (GLP-1R) agonist .
loading...
    loading...
Cat. No.: HY-P11818
GIPR/GLP-1R/GCGR agonist-1 (compound 686) is a triple receptor agonist with activity at GLP-1R, GIPR, and GCGR. GIPR/GLP-1R/GCGR agonist-1 functionally modulates target receptors to drive cAMP generation. GIPR/GLP-1R/GCGR agonist-1 can be used for the research of type 2 diabetes mellitus, obesity, nonalcoholic fatty liver disease .
loading...
    loading...
Cat. No.: HY-13443C
Exendin-4-Cys is a cysteine-modified Exendin-4 (HY-13443). Exendin‑4 (Exenatide) is an orally active, blood-brain barrier-permeable glucagon-like peptide-1 receptor (GLP‑1 receptor) agonist .
loading...
    loading...
  • 1